Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
11/01/1990 | WO1990009806A3 Composition for the inhibition of tumors and for the non-cytotoxic inhibition of replication of viruses |
11/01/1990 | WO1990008583A3 Thyroleberin as immunomodulator and lipid regulator |
11/01/1990 | WO1990000607A3 Gap gene sequences and diagnostic uses thereof |
11/01/1990 | CA2053250A1 Linear somatostatin analogs |
10/31/1990 | EP0395418A1 A phospholipase A2 inhibitor, method for producing it and pharmaceutical or veterinary formulations comprising said inhibitor |
10/31/1990 | EP0395417A1 Linear somatostatin analogues |
10/31/1990 | EP0395375A1 Novel DNA sequences which encode ancrod-like polypeptides and compositions comprising the expression products thereof |
10/31/1990 | EP0395357A2 Polyamines useful as antagonists of excitatory amino acid neurotransmitters and/or as blockers of calcium channels |
10/31/1990 | EP0395120A2 Method of passive immunization of mammals using bovid antibody and compositions for same |
10/31/1990 | EP0394989A2 Peptide compounds, process for preparation thereof and pharmaceutical composition comprising the same |
10/31/1990 | EP0394951A1 Glycosylated bFGF and production thereof |
10/31/1990 | EP0394946A2 Human monoclonal antibody, and its production and use |
10/31/1990 | EP0394872A1 Interferon for the use in the prevention or treatment of swine pneumonia or related bacterial diseases |
10/31/1990 | EP0394853A1 Dipeptide-derivatives with enzym-inhibiting activity |
10/31/1990 | EP0394829A1 Renin-inhibiting dipeptides, process to synthetize them, compositions containing them and their use |
10/31/1990 | EP0394827A1 Chimaeric CD4-immunoglobulin polypeptides |
10/31/1990 | EP0394349A1 Wound healing. |
10/31/1990 | EP0394326A1 Conformationally stabilized cell adhesion peptides. |
10/31/1990 | EP0394311A1 Renin inhibiting peptides that contain amino and hydroxy dicarboxylic acids |
10/31/1990 | EP0394302A1 DNA ENCODING IgE RECEPTOR $g(a)-SUBUNIT OR FRAGMENT THEREOF |
10/31/1990 | EP0394297A1 Anti-retroviral agent |
10/31/1990 | EP0394277A1 Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same |
10/31/1990 | EP0394261A1 Novel thrombolytic proteins |
10/31/1990 | EP0236452B1 Enhanced bioactivity of mammalian somatotropin through selective deamidation |
10/31/1990 | EP0188810B1 Use of dipeptide derivatives for the prevention or treatment of post-traumatic spinal and/or cerebral nerve disorders |
10/31/1990 | DE3913791A1 Pharmaceutical compound for treating tumours - comprises xanthogenate, fatty acid and tumour necrosis factor |
10/31/1990 | DE3913101A1 DNA encoding TNF binding protein and TNF- receptor |
10/31/1990 | CN1046464A Method for reducing side effects of drug |
10/31/1990 | CN1046462A Composition and treatment with biologically active peptides and antibiotic |
10/30/1990 | US4966964 Inhibitors of angiogenin |
10/30/1990 | US4966962 Reverse analogue of actinomycin D |
10/30/1990 | US4966889 Treatment of inflammatory articular diseases |
10/30/1990 | US4966888 hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, antibodies thereto and contraceptive vaccine |
10/30/1990 | US4966852 DNA clone of human tissue factor inhibitor |
10/30/1990 | US4966851 Process for isolation of lysozyme and avidin from egg white |
10/30/1990 | US4966849 CDNA and genes for human angiogenin (angiogenesis factor) and methods of expression |
10/30/1990 | US4966843 Expression of interferon genes in Chinese hamster ovary cells |
10/30/1990 | US4966774 Antiinflammtory agents, a remedy for cardiac disorder, storage stability |
10/30/1990 | US4966753 Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms |
10/29/1990 | WO1990013561A1 Therapeutic agent |
10/29/1990 | WO1990013291A1 Beta-hydroxamate d-aspartic acid for treatment of viral infections and tumours |
10/29/1990 | CA2443232A1 Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics |
10/29/1990 | CA2050936A1 Beta-hydroxamate d-aspartic acid for treatment of viral infections and tumours |
10/29/1990 | CA2015735A1 Glycoprotein from avena sativa, process for its preparation, and pharmaceutical compositions containing same |
10/28/1990 | WO1990012597A1 Fibroblast growth factor conjugates |
10/28/1990 | WO1990012586A1 Drugs (calcitonin gene-related peptides) for treating erectile dysfunctions |
10/28/1990 | CA2015359A1 Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same |
10/26/1990 | CA2015313A1 Glycosylated fgf and production thereof |
10/26/1990 | CA2015127A1 Novel dna sequences which encode ancrod-like polypeptides and compositions comprising the expression products thereof |
10/25/1990 | DE3938233A1 Compsns. for treating venous inflammations - contain specified enzymes, microorganisms or plant extract |
10/24/1990 | EP0394035A2 Genes coding for a protein having human macif activity, expression vectors containing said genes, transformant cells and proteins having human macif activity |
10/24/1990 | EP0393934A1 Novel peptides, and antidementia agents containing the same |
10/24/1990 | EP0393883A1 Novel cytotoxic cyclic depsipeptides from the tunicate trididemnum solidum |
10/24/1990 | EP0393850A2 Process for producing kappa-casein glycomacropeptides |
10/24/1990 | EP0393786A1 New retro-inverse, one- or more bond bearing analogues of thymopentin, a method for synthesizing the same and their employment for the preparation of pharmaceutical |
10/24/1990 | EP0393781A2 Dopamine pro-drug |
10/24/1990 | EP0393725A1 Process for activating genetically-engineered, heterologous eucaryotic proteins containing disulphide bridges after their expression in procaryotes |
10/24/1990 | EP0393707A2 Bioactive compounds associated with liposomes and their use in pharmaceutical preparations |
10/24/1990 | EP0393502A1 Soluble interferon-gamma receptors and methods for their production |
10/24/1990 | EP0393457A1 Proteinase inhibitor |
10/24/1990 | EP0393445A2 Use of peptide renin inhibitors as an agent against retrovirus |
10/24/1990 | EP0393441A1 Mercapto-acylamino acids |
10/24/1990 | EP0393438A2 TNF-receptor, TNF-binding protein and DNA coding therefor |
10/24/1990 | EP0393431A1 Homologues of Alzheimer protease inhibitor prepared genetechnologically, host-strains and expression vectors for their preparation and use as a medicament |
10/24/1990 | EP0393143A1 Cloned dna for synthesizing unique glucocerebrosidase |
10/24/1990 | EP0393140A1 Topical wound-healing preparations comprising interleukin-1 proteins. |
10/24/1990 | EP0393062A1 Monoclonal antibody that recognizes an epitope of the gamma chain of human t cell surface receptors |
10/24/1990 | EP0393045A1 Fv antibody fragment production |
10/24/1990 | EP0393035A1 Method for the isolation of active enzyme(s) from krill tissue. |
10/24/1990 | EP0383764A4 Bovine granulocyte-macrophage colony stimulating factor |
10/24/1990 | EP0325639A4 Fibrin-binding compound and method |
10/24/1990 | CN1046335A Ribosome inactivating proteins and derivatives thereof |
10/24/1990 | CN1010097B Method of somatotropin solubilization and naturation |
10/24/1990 | CA2015246A1 Human monoclonal antibody, and its production and use |
10/24/1990 | CA2015003A1 Interferon for the use in the prevention or treatment of swine pneumonia or related bacterial diseases |
10/23/1990 | US4965251 Pulse treatment of hemoglobinopathies with erythropoietin |
10/23/1990 | US4965250 Peptide compounds having a nitrogenous polycyclic structure |
10/23/1990 | US4965203 Purified thrombin preparations |
10/23/1990 | US4965199 Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
10/23/1990 | US4965195 Interleukin-7 |
10/23/1990 | US4965069 Oxidized viruses or viral antigens and utilization for diagnostic prophylactic and/or therapeutic applications |
10/23/1990 | US4965068 Useful against grampositive and gramnegative bacteria |
10/23/1990 | US4964848 Treatment of multiple sclerosis with lymphocytapheresis and chemo-immunosuppression |
10/23/1990 | CA1275550C Tripeptide and tetrapeptide esters which inhibit gastric secretion, process for their preparation and pharmaceutical compositions in which they are present |
10/22/1990 | WO1990012809A1 Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient |
10/22/1990 | WO1990012592A1 Recombinant antibody-toxin fusion protein |
10/22/1990 | CA2015071A1 Renin-inhibiting dipetides, a process for their preparation, agents containing them and their use |
10/22/1990 | CA2015070A1 Dipetide derivatives having enzyme-inhibitory action |
10/21/1990 | WO1990012579A1 The use of non-absorbable synthetic sulfated polysaccharides to decrease cholesterol absorption |
10/21/1990 | CA2015053A1 Retro-inverse, one- or more-bond bearing analogues of thymopentin, a method for synthesizing the same and their employment for the preparation of pharmaceutical |
10/20/1990 | WO1990013540A1 Active carbonates of polyalkylene oxides for modification of polypeptides |
10/20/1990 | CA2014896A1 Hepatospecific insulin analogues |
10/19/1990 | WO1990012812A1 Proteins which regulate the expression of vertebrate mhc class ii genes, dna sequences encoding them and pharmaceutical compositions |
10/19/1990 | CA2031507A1 Proteins which regulate the expression of vertebrate mhc class ii genes, dna sequences encoding them and pharmaceutical compositions |
10/19/1990 | CA2014939A1 Therapeutic compounds, compositions and uses thereof |
10/19/1990 | CA2014752A1 Soluble interferon-gamma receptors and methods for their production |
10/18/1990 | WO1990012344A1 Fast printer with a particle trap in the paper channel |
10/18/1990 | WO1990012112A1 A new method for the diagnosis of virulent bacteria |
10/18/1990 | WO1990012091A1 Urokinase-type plasminogen activator receptor |
10/18/1990 | WO1990012087A1 Infectious targetted replication-defective virion |